HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Sureda Selected Research

14-thioglycolamido-7,8-dihydromorphinone (TAMO)

4/2005Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.
10/2004Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.
12/2003High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
1/2003High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Sureda Research Topics

Disease

15Hodgkin Disease (Hodgkin's Disease)
01/2022 - 02/2000
11Lymphoma (Lymphomas)
01/2022 - 12/2007
8Multiple Myeloma
11/2017 - 04/2000
7Neoplasms (Cancer)
05/2020 - 11/2000
7Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 11/2000
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2003
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2005 - 02/2000
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2016 - 03/2011
4Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2016 - 02/2000
3Febrile Neutropenia
02/2021 - 01/2018
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 12/2003
3Immune System Diseases (Immune Disorders)
08/2015 - 03/2006
3Graft vs Host Disease (Graft-Versus-Host Disease)
12/2009 - 11/2000
2Inflammation (Inflammations)
05/2021 - 01/2016
2Infections
02/2021 - 05/2002
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2020 - 01/2020
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2017 - 01/2008
2Hypoxia (Hypoxemia)
09/2015 - 07/2006
2Apnea
09/2015 - 07/2006
2Mucositis
09/2010 - 05/2002
2Seizures (Absence Seizure)
01/2007 - 05/2006
2Iron Overload
09/2004 - 06/2002
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2003 - 07/2000
2Fever (Fevers)
05/2002 - 11/2001
2Fever of Unknown Origin
11/2001 - 09/2000
1Intestinal Perforation
02/2021
1Pulmonary Embolism
02/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2021
1Pneumonia (Pneumonitis)
02/2021
1HIV Infections (HIV Infection)
02/2021
1Cardiac Arrhythmias (Arrythmia)
02/2021
1Unstable Angina
02/2021
1Mental Disorders (Mental Disorder)
02/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
02/2021
1COVID-19
02/2021
1Diverticulitis
02/2021
1Heart Failure
02/2021
1Hypersensitivity (Allergy)
02/2021
1Respiratory Tract Diseases (Respiratory Tract Disease)
02/2021
1Respiratory Insufficiency (Respiratory Failure)
02/2021
1Sepsis (Septicemia)
02/2021
1Mycosis Fungoides
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

414-thioglycolamido-7,8-dihydromorphinone (TAMO)IBA
04/2005 - 01/2003
3Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 09/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 04/2004
3Melphalan (Alkeran)FDA LinkGeneric
02/2016 - 11/2003
3AntioxidantsIBA
09/2015 - 07/2006
2Oxygen (Dioxygen)IBA
02/2021 - 09/2015
2CreatinineIBA
02/2021 - 01/2000
2Etoposide (VP 16)FDA LinkGeneric
02/2016 - 02/2000
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2016 - 12/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2015 - 07/2006
2fludarabineIBA
01/2009 - 11/2003
2Pilocarpine (Ocusert)FDA LinkGeneric
01/2007 - 05/2006
2Cholinergic AgonistsIBA
01/2007 - 05/2006
2Busulfan (Busulfex)FDA Link
07/2006 - 11/2003
2Free RadicalsIBA
09/2004 - 06/2002
2InterferonsIBA
12/2001 - 02/2000
1MicroplasticsIBA
05/2021
1tocilizumab (atlizumab)FDA Link
02/2021
1BilirubinIBA
02/2021
1Alkaline PhosphataseIBA
02/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2021
1remdesivirIBA
02/2021
1baricitinibIBA
02/2021
1LactamsIBA
05/2020
1Cefepime (Maxipime)FDA LinkGeneric
05/2020
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
05/2020
1Meropenem (Merrem)FDA LinkGeneric
05/2020
1Ki-1 AntigenIBA
01/2020
1Brentuximab VedotinIBA
01/2019
1Lenalidomide (CC 5013)FDA Link
11/2017
1pomalidomideIBA
11/2017
1Alkylating AgentsIBA
11/2017
1carfilzomibIBA
11/2017
1Bortezomib (Velcade)FDA Link
11/2017
1Janus Kinase InhibitorsIBA
02/2017
1Carmustine (FIVB)FDA Link
02/2016
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
02/2016
1EicosanoidsIBA
01/2016
1Xanthine OxidaseIBA
09/2015
1NitrogenIBA
09/2015

Therapy/Procedure

37Stem Cell Transplantation
01/2022 - 01/2000
16Transplantation
01/2021 - 02/2000
13Therapeutics
05/2020 - 01/2000
12Drug Therapy (Chemotherapy)
05/2020 - 01/2000
6Hematopoietic Stem Cell Transplantation
01/2021 - 11/2001
5Autologous Transplantation
01/2016 - 05/2000
4Homologous Transplantation
05/2014 - 07/2005
3Radiotherapy
01/2019 - 02/2000
2Cell Transplantation
11/2015 - 05/2014
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
07/2006 - 11/2000
2Time-to-Treatment
04/2005 - 03/2001
1Cannula
02/2021
1Extracorporeal Membrane Oxygenation
02/2021
1Artificial Respiration (Mechanical Ventilation)
02/2021
1Prostatectomy (Retropubic Prostatectomy)
01/2019
1Brachytherapy
01/2019
1Length of Stay
01/2018